HLA-DRB1 and rheumatoid arthritis: Although prediction of progressive joint damage in RA patients is still far from perfect, the use of identified risk factors (HLA-DRB1-SE positive, PADI4 risk allele positive, ACPA positive, younger age of onset and female sex) should make it easier for rheumatologists to make their treatment decisions in the future.